Wellington Management Group LLP Acadia Pharmaceuticals Inc Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 62,585 shares of ACAD stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,585

Previous 64,774 3.38%

Holding current value

$1.07 Million

Previous $1.05 Million 8.46%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $33,141 - $41,897	-2,189 Reduced 3.38%	62,585 $963,000
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $95,132 - $119,858	6,507 Added 11.17%	64,774 $1.05 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.04 Million - $1.8 Million	58,267 New	58,267 $1.08 Million
Q4 2023 Feb 12, 2024	BUY	$20.78 - $31.77 $810,149 - $1.24 Million	38,987 New	38,987 $1.22 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $6.52 Million - $8.35 Million	-399,273 Reduced 25.27%	1,180,637 $22.2 Million
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $1.89 Million - $2.48 Million	-132,877 Reduced 7.76%	1,579,910 $25.2 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $13.4 Million - $17.3 Million	949,196 Added 124.31%	1,712,787 $28 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $9.93 Million - $20.8 Million	763,591 New	763,591 $10.8 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $24.7 Million - $38.6 Million	-677,709 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $5.85 Million - $7.85 Million	-148,952 Reduced 18.02%	677,709 $32.8 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $5.34 Million - $7.91 Million	168,716 Added 25.64%	826,661 $34.9 Million
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $23.8 Million - $33.8 Million	657,945 New	657,945 $28.1 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Acadia Pharmaceuticals Inc Transaction History